ReNeuron Group Plc  

(Public, LON:RENE)   Watch this stock  
Find more results for D. Huggins
+0.18 (6.21%)
Apr 23 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 3.05 - 3.25
52 week 2.02 - 4.30
Open 3.05
Vol / Avg. 1.81M/1.31M
Mkt cap 56.62M*
P/E     -
Div/yield     -
EPS -0.01*
Shares 1.79B
Beta     -
Inst. own     -

Key stats and ratios

Q3 (Sep '13) 2013
Net profit margin -28790.91% -37323.53%
Operating margin -31754.54% -41694.12%
EBITD margin - -40976.47%
Return on average assets -38.15% -97.74%
Return on average equity -41.69% -125.12%
Employees 23 -
CDP Score - -


10 Nugent Rd, Surrey Research Park
United Kingdom - Map
+44-1483-302560 (Phone)
+44-1483-534864 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


ReNeuron Group Plc (ReNeuron) is a United Kingdom-based company engaged in clinical-stage stem cell business. The Company is engaged in the research, development and commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications. It used its stem cell technologies to develop cellbased therapies for disease conditions where the cells can be readily administered off-the-shelf to any eligible patient without the need for additional drug treatments. Its lead therapeutic candidate is its ReN001 stem cell therapy for the treatment of patients left disabled by the effects of a stroke. It is also developing stem cell therapies for other conditions, such as peripheral arterial disease and blindness-causing diseases of the retina. It has a range of stem cell lines for non-therapeutic applications. Its ReNcell products are used in academic and commercial research. The Company´┐Żs ReNcellCX and ReNcellVM neural cell lines are marketed globally.

Officers and directors

Michael Elliott Hunt Chief Executive Officer, Executive Director
Age: 49
John D. Sinden Ph.D. Chief Scientific Officer, Executive Director
Age: 61
Patrick Huggins Company Secretary
Bryan Geoffrey Morton Ph.D. Non-Executive Chairman of the Board
Age: 56
John Edward Berriman Non-Executive Director
Age: 66
Simon C. Cartmell Non-Executive Director
Tim Corn Non-Executive Director
Age: 61
Mark Docherty Non-Executive Director
Age: 48